Optimized Production of 188 Re-HYNIC-Bombesin: New Therapeutic Agent for GRPR Targeting.

Sara VosoughiNafise SalekSamaneh ZolghadriSeyed Mahmoud Reza AghamiriMilad Delavari

Published in: Nuclear medicine and molecular imaging (2024)

Re-HYNIC-BBN as a new therapeutic agent for targeting GRPRs, however, more biological data is still needed.

Keyphrases